Mariana Kikuti1, Laura B Tauro2, Patrícia S S Moreira3, Leile Camila J Nascimento3, Moyra M Portilho3, Gúbio C Soares4, Scott C Weaver5, Mitermayer G Reis1, Uriel Kitron6, Guilherme S Ribeiro7. 1. Fundação Oswaldo Cruz, Salvador, Bahia, Brazil; Universidade Federal da Bahia, Salvador, Bahia, Brazil. 2. Fundação Oswaldo Cruz, Salvador, Bahia, Brazil; Instituto de Biología Subtropical, nodo Iguazú, CONICET, UNaM, Puerto Iguazu, Misiones, Argentina. 3. Fundação Oswaldo Cruz, Salvador, Bahia, Brazil. 4. Universidade Federal da Bahia, Salvador, Bahia, Brazil. 5. University of Texas Medical Branch, Galveston, TX, USA. 6. Fundação Oswaldo Cruz, Salvador, Bahia, Brazil; Emory University, Atlanta, GA, USA. 7. Fundação Oswaldo Cruz, Salvador, Bahia, Brazil; Universidade Federal da Bahia, Salvador, Bahia, Brazil. Electronic address: guilherme.ribeiro@bahia.fiocruz.br.
Abstract
OBJECTIVE: To evaluate the diagnostic performance of the Inbios (Seattle, US) and Euroimmun (Luebeck, Germany) chikungunya virus (CHIKV) IgM enzyme-linked immunoassays (ELISAs). METHODS: We evaluated the tests' accuracy on sera from 372 patients enrolled in an acute febrile illness surveillance study performed in Salvador, Brazil from Sept/2014 to Jul/2016, a period of simultaneous CHIKV, dengue (DENV), and Zika (ZIKV) virus transmission. We assessed the sensitivity on acute and paired convalescent sera from RT-PCR-confirmed CHIKV cases (collected at median one and 19 days post-onset of symptoms, respectively), and the specificity on sera of RT-PCR-confirmed DENV and ZIKV cases, and on negative patients. RESULTS: The Inbios and Euroimmun tests' sensitivities for acute samples were 4.0% and 10.3%, while for convalescent samples they were 92.4% and 96.9%, respectively. Overall, Inbios IgM ELISA specificities for acute and convalescent samples were 97.7% and 90.5%, respectively, and Euroimmun specificities were 88.5% and 83.9%, respectively. CONCLUSIONS: Both tests presented high sensitivity for convalescent samples. However, the Euroimmun test returned more equivocal results and presented a slightly lower specificity, which might result in a higher rate of false positives if the test is used in scenarios of low CHIKV transmission, when the chance of CHIKV infection is lower.
OBJECTIVE: To evaluate the diagnostic performance of the Inbios (Seattle, US) and Euroimmun (Luebeck, Germany) chikungunya virus (CHIKV) IgM enzyme-linked immunoassays (ELISAs). METHODS: We evaluated the tests' accuracy on sera from 372 patients enrolled in an acute febrile illness surveillance study performed in Salvador, Brazil from Sept/2014 to Jul/2016, a period of simultaneous CHIKV, dengue (DENV), and Zika (ZIKV) virus transmission. We assessed the sensitivity on acute and paired convalescent sera from RT-PCR-confirmed CHIKV cases (collected at median one and 19 days post-onset of symptoms, respectively), and the specificity on sera of RT-PCR-confirmed DENV and ZIKV cases, and on negative patients. RESULTS: The Inbios and Euroimmun tests' sensitivities for acute samples were 4.0% and 10.3%, while for convalescent samples they were 92.4% and 96.9%, respectively. Overall, Inbios IgM ELISA specificities for acute and convalescent samples were 97.7% and 90.5%, respectively, and Euroimmun specificities were 88.5% and 83.9%, respectively. CONCLUSIONS: Both tests presented high sensitivity for convalescent samples. However, the Euroimmun test returned more equivocal results and presented a slightly lower specificity, which might result in a higher rate of false positives if the test is used in scenarios of low CHIKV transmission, when the chance of CHIKV infection is lower.
Authors: Carlo Fischer; Fernando Bozza; Xiomara Jeanleny Merino Merino; Celia Pedroso; Edmilson F de Oliveira Filho; Andrés Moreira-Soto; Alvaro Schwalb; Xavier de Lamballerie; Eduardo Martins Netto; Patrícia T Bozza; Manoel Sarno; Carlos Brites; Eduardo Gotuzzo; Michael Talledo; Jan Felix Drexler Journal: mSphere Date: 2020-02-05 Impact factor: 4.389
Authors: Ankita Reddy; Irene Bosch; Nol Salcedo; Bobby Brooke Herrera; Helena de Puig; Carlos F Narváez; Diana María Caicedo-Borrero; Ivette Lorenzana; Leda Parham; Kimberly García; Marcela Mercado; Angélica María Rico Turca; Luis A Villar-Centeno; Margarita Gélvez-Ramírez; Natalia Andrea Gómez Ríos; Megan Hiley; Dawlyn García; Michael S Diamond; Lee Gehrke Journal: Viruses Date: 2020-09-01 Impact factor: 5.048
Authors: Karol Suchowiecki; St Patrick Reid; Gary L Simon; Gary S Firestein; Aileen Chang Journal: Curr Rheumatol Rep Date: 2021-04-13 Impact factor: 4.592
Authors: Leonardo Assis da Silva; Monique da Rocha Queiroz Lima; Brenda Rabello de Camargo; Dyeferson Kened da Silva Coelho Guimarães; Anabele Azevedo Lima Barbastefano; Raquel Curtinhas de Lima; Paulo Vieira Damasco; Rivaldo Venâncio da Cunha; Luiz José de Souza; Elzinandes Leal de Azeredo; Luzia Maria de-Oliveira-Pinto; Tatsuya Nagata; Daniel M P Ardisson-Araújo; Flavia Barreto Dos Santos; Bergmann Morais Ribeiro Journal: Microorganisms Date: 2022-07-18